March Planning Registration: Fill & Download for Free

Originally Posted on my blog- Life at ISB in 51 Facebook UpdatesMy mind was a mumbo-jumbo of self-deprecating thoughts while entering the gates of this school. I had dreamed of it right since 2013, my 3rd year of Dental School when I actually decided to pursue an MBA post graduation. From letting go of all the revelry of my internship year (called as the ‘honeymoon’ period of Dentistry) to registering my startup, and finally dumping clinical dentistry for Digital Marketing as my choice of job immediately after graduating, most of my career steps were aimed to strengthen my candidature for ISB. I was grateful enough to soon bag a seat through the EEO (Early Entry Option), but when the time finally arrived (after one year of waiting) to join, I got cold feet. I had absolutely no clue if the big risk that I had taken was worth it or if I would be able to even survive the one year with my sanity at its place.Now, when the time is almost ripe to leave this ‘temple of transformation’, all I have to say is that this place has completely changed me who I was, has changed my perspective of everything I had believed in, made me test the deep waters and then gave me enough strength to pull myself out of it!The aim of this post is simple- to keep the memories of this remarkable and ‘status-quo-changing’ year in a quirky way, that is ‘just a bookmark’ away. All of the facebook posts here are mine and hence from my personal perspective (Duh!), but I am sure everyone who has experienced #LifeAtISB will be able to relate to 90% of them.15th April 2017 was the day when we all entered ISB- the chaotic but well-planned registration process, lots of Hi-hellos with people whom we had met at those city meetups was followed by the welcome dinner. We all had a peaceful sleep in our beautifully done quad, before the hell broke loose. . .From ‘hell’. I didn’t mean those outdoors of O-Week, but that Simulation Competition in LEAD, followed by the Math Bootcamp. I, who hadn’t seen numbers in ages, got a fair share of idea of what I had signed up for, how challenging the next year is going to be for me (I am sure, non-maths, non-commerce cohort of ISB will understand).Who would have imagined that our 1st Group Assignment will be such a deadly one. While we broke our head overnight on launching the feasible brand of detergent in Brazil, we got to know our 1st ever study group more closely (for the better or worse). I remember meeting some drunk people on the bench near SV1 at 5 AM on my way back to my quad after submitting the assignment. They forced me to accompany them to the dam, where we had two pints of beer each. I returned at around 10 AM, only to bunk all the afternoon lectures- Life at ISB had begun!Meanwhile life went on with SMMD in-class quizzes, FADM off-class quizzes, MGEC hard-copy homeworks and faffing our way to Marketing Management.We were still getting used to the deadlines when I already had the live horror experience (sounds too exaggerated now, but things were different back then). I slept off in the mid of the assignment and had to pull off a ninja attack to submit it in time- 8 seconds early is still the best record of mine!Describing #LifeAtISB would be incomplete without giving proper worth to the reptiles. I remember someone spotted a live scorpion in the commode (No Kidding!) in SV4. We realized snakes and the impending mid-term results were not the only stuff we were supposed to be afraid of, there were scorpions too.I don’t remember what was this night about, except a couple of friends and alums had gathered in my room over scotch.Well, you can ignore this one. There are a few stupidities only I am entitled to be involved with. . .I still remember the relief after finishing that Marketing Management paper, full of essays & what not! Neither had I any clue what the big bad DMOP has in store for me, nor I knew that this would be the one of the best term breaks for a long long time (because the next term breaks were nothing but farce)It was a weird feeling when I realized I had actually started liking the curriculum and the course, at a point when both were screwing me the most!Term 2 started with my Birthday and as they say Birthdays at ISB are always special. With aching bums, broken slippers and mixture of cake and soda smashed on my face, I started the so-called ‘Hell Term’I don’t know why I wrote this? End Term results weren’t out and Term 2 had hardly started. Looks like another post under the influence of holy spirits.DMOP Quiz, never ending cases of Comp Strat, weekly submissions of GLEC Country Reports (I know more about the Chilean Economy than the Indian one, thank you GLEC), MarkStrat discussions stretching beyond 6 hours- still get goosebumps on thinking about those sleep-deprived days.Meanwhile, number of people in the campus who threw a ‘Dentists are not Doctors’ on my face kept increasing. I don’t know if we the Dentists are Doctors or not, but it was always a gratifying feeling to provide consultation at those wee hours.Term 2 also introduced us to ‘random’ lectures and sessions. There were lectures by alums, leadership talks by ‘more successful’ alums, peer-to-peer sessions by ‘more intelligent’ classmates and so on. While FOMO tightened its grip, I am sure we all eventually learnt what to attend, what to resist and what to attend for a few minutes before walking off.The campus turned rainbow for the Pride Month with the LGBT flag flying high. Pictures on Facebook informed me about a colorful Pride March across the campus, which I missed because I was sleeping (no comments)I take these words back. I couldn’t have been happier, and definitely not while doing RCTs.‘The Kale’ arrived for the second part of Comp Strat and left the mortals of Sections EFGH bewildered, amused and mystified. Even apparently non-active users of Facebook were seen updating their status, expressing joys, jubilation and AHA moments over Professor Prashant Kale‘s lectures. Sadly, it ended too soon.One of my major regrets at ISB would be that I still have no clue what the hell happened in the 2nd half of DMOP.11:40 PM : Ran like a ninja from SV1 to LRC for taking the printout11: 52 PM : Got the printout11:57 PM : SubmittedI still remember Chile has a huge reserve of Copper and is the fastest growing economy of Latin America. Damn you GLEC!Term 3 started with case competitions, ELPs and Live Projects. Live Projects were good, the ones which paid me and the manager took us out for drinks were better.Well. . . . . .Term 3 basically had no chill- Case competitions bombarded us faster than we expected and CFIN case assignments showed us the extreme ends of suffering (applicable for those who didn’t have CAs & CFAs in their study groups)Loved the way how my 2 AM rant on CFIN was immediately supported by equally frustrating rants on MADM & OPMG. Phew!I do agree that this sounds funny. But there was something in that first bidding along with the crazy cohort of Section G that got me excited enough (which is very often) to put up this status.I never understood Operations clearly, till Professor Sarang Deotaught it in the Healthcare Context in Term 8.How can we forget those belligerent combats during negotiations. Introduction to NEGA gave us a superficial realization that placements are near and very soon we will be on the table negotiating our own worth with someone who has no clue who we are.ELP was the best learning experience at ISB. Designing the conjoint survey, getting the ‘difficult to understand’ survey filled with random strangers in Inorbit and GVK Malls, adhering to deadlines amidst everything that was happening in the campus, making sure that the client & our team were on the same page- I can’t put in words how effectual the entire experience was for me personally. If you are someone who is reading this prior to joining ISB- do take up ELP if you get a chance.What a show ILS was! Take a bow Dawda & Team.A special note for Section G- You guys have been amazing! And it’s not for the crazy time we have had together (infact I couldn’t attend even half the birthday gatherings & parties), but for the fact that ‘almost’ everyone exudes genuine warmth and everyone greets everyone with the kindest smile possible. #SectionGAlways , indeed.Aaaand..came the resume making season. I wish I could honestly write what all went behind building those resume points. But let’s not go there. . .Amidst all the craziness and the imminent placement week, we celebrated Diwali. Some people chose to wear ethnic and got themselves clicked at the Rec Center (Facebook was spammed once again that day). While I just chose to glorify my clean room (which was actually cleaned by the house keeping), put some fairy lights to make it look Instagram-able, distributed sweets to all the security guards across campus who couldn’t celebrate and finally ended the day with Old Monk (sourced by someone from Bangalore) with a few close friends who made everyone feel awkward with inappropriate questions for Truth & Dare. It was a memorable night.You can ignore this one. . . .Another week of an ‘overdose of submissions’. What made it worse was the fact that Placements were just 15 days away.Term 5, when everyone chose such electives where they don’t have to study much so that placement preparation gets the full attention. Don’t ask me why I took ‘Portfolio Management‘. Even I have no clue.I distinctly remember this one- I had posted this just before leaving for the pre-process of Day 1. It was one of the most difficult days at ISB for most of us, both mentally & physically. It will take me a separate blogpost to describe the entire placement season and I would leave that for some other time.I consider myself extremely lucky to get out of the placement process without feeling much heat. And I have huge respect & admiration for the people who had to go through it for a little longer without losing their sanity. Nevertheless, the relief after the placement was ‘unearthy’. Life at ISB literally changed beyond this point.I saw people breaking down after rejection ,then getting up immediately with full vigor and a wide smile for the next interview. I saw people jumping of joy after signing the offer, and I also saw the disappointed look on the face of people after signing the offer. A friend broke down in front of me after not getting any offer at the end of Day 2.1 and then miraculously got a call from HR at the end of Day 2.2 offering him the job (Later he told me, “You are the worst person to cry in front of”). Another friend asked if she can get a hug after she signed a offer she was not quite happy with. As I said, I need another blogpost to write about the placement season in detail. . .We were so happy after getting placed that we went out to celebrate even before the final ELP presentation to the client.Section G has been so cool that our Awards Night was accompanied with a Roast! It was remarkable because we couldn’t have done a roast session without offending people unless we were really close to each other as a section. Whatttta show!The dormant foodie in us got unleashed post placement. We all found ourselves visiting and recommending each other fancy places to eat & drink across the city of Nizams. Kabul Darbar deserves a special mention just for this Raan!Life in ISB is also about Life in Hyderabad. And the midnight ride to the Charminar will always be cherished. We even took the vegetarians to Shadab, though I don’t remember what did those poor souls order to eat there.And there came the Solstice! 3 days of unadulterated alcohol & fun. The highlight of Solstice was the moment when Vishal (Or was it Shekhar?) said “I can smell what’s going up in the air”. #RevelryMaxTerm 7, with the end of Day 3 & 4, witnessed an exponential increase in the number of parties and decrease in amount of collective attention in the lectures.But what didn’t slow down were the assignments, submissions and deadlines! We even had strict deadlines (which got extended 97 times) to write testimonials for the yearbook.Writing Testimonials was another time when we all got creative (it happened for the first time during the resume writing season). Sweet words were exchanged and promises to keep in touch were made. Few people wrote testimonials because they felt like, while others wrote just to ‘return the favor’Term 8 started with the ‘Emails about Graduation’ and random trips, outings and more parties. While we reveled and got ourselves drenched in hedonism, the sinking feeling of ‘It’s getting over’ increased with each passing day.We really pushed ourselves to ‘extract’ as many number of meetups/parties as possible- UG College Meetup, Club Members meetup, 1st Study Group Meetup, ‘The Best Ever’ study group Meetup, Meetup because someone had ‘stuff’, Meetup because ‘One year at Hyderabad still haven’t seen Charminar yet’, Birthday Meetups because someone’s birthday was post Convocation and the list goes on. . .Group Assignments became a nightmare when people stopped replying on the Whatsapp Study Groups (because, priorities). “Kuch bhi likh ke submit kar de yaar” became a norm. I really pity the AAs and Professors of Term 8. Reading up those write-ups must have been upsetting.HeyDay came with #TakeMeBackToTheStart and the realization finally started to sink in- It was time to get out of the cocoon and face the real world.And then, just like that we had our last lecture. Pictures of name-cards flocked Facebook & Instagram (while few thought that they were too cool for that). No matter how each one’s experience had been at ISB, but the realization that the extra-ordinary classroom learning had ended finally, really hit hard.I started working on this blogpost around 2 months ago (scrolling down to extract meaningful stuff from the garbage I post was difficult) and I had initially thought of putting up 51 updates (signifying the 51 weeks at ISB), ending the last update with our graduation. Tomorrow we all will graduate and cross over to our next phase of life. But in a parallel imaginary world, I would forever want to be a student at the Indian School of Business. Hence, there won’t be the 51th update to this post. ISB is going to stay.Happy Graduation to one and all. Attraversiamo (Let’s cross over together to the other side).

Publication of study results in academic journals depends on various considerations - the publication strategy, decisions of Steering Committees or Publication Committees, etc. Of course, the sponsor (company) has a role to play here.However, reporting of study results is not limited to publications. There is another, more important mode of reporting, which is mandated by regulations now.Clinical study reporting is now required by multiple regulations. Often, registration on the US government portal - ClinicalTrials.gov - is required. The image below shows the timeline of how regulation around trial registration on ClinicalTrials.gov was established.Timeline of the regulations around reporting on ClinicalTrials.gov. Source: History, Policies, and LawsIn the year 2000, NIH set up the ClinicalTrials.gov portal, and over the years, the scope has been increased by inviting comment from bodies such as the FDA and the general public. Requirements for reporting summary results and safety (adverse events) reporting have been set up.Over time, some influential organizations mandated the registration of trials on these portals, and compliance with reporting requirements. For example, the International Committee of Medical Journal Editors requires trial registration as a condition of publication. The World Health Organization also took up the registration of clinical trials internationally, and links various registries from other countries, such as EU CTR (for EU), as well as ClinicalTrials.gov. The touchstone principle in clinical research, the Declaration of Helsinki also enshrines prospective registration of studies before recruitment of the first subject, and disclosure of study results as ethical obligations. The Final Rule is now in place and is effective from January 18, 2017 and parties are expected to be in compliance as of April 18, 2017.Thus it is clear that any industry sponsor that wants to continue doing business needs to carefully comply with these requirements.On exploration of ClinicalTrials.gov, one notes the explanation for why study results may not be posted on the portal.No Study Results PostedWhen results are not available for a study, the results tab is labeled "No Study Results Posted." Results of a study may not be posted on ClinicalTrials.gov for any of the following reasons:The study may not be subject to U.S. Federal requirements to submit results. See FDAAA 801 Requirements: When Do I Need to Register and Submit Results?The study is ongoing.The study has been completed, but the deadline for results submission has not passed.The results have been submitted but have not yet been posted (for example, pending review by ClinicalTrials.gov).The submission of results information has been delayed by the submission of a certification or a request to extend the results submission deadline. See FDAAA 801 Requirements: When Do I Need to Register and Submit Results?Source: About the Results DatabaseThere are clauses for delay or extension of reporting of study results, and an establishment of deadlines. This is contingent on whether or not the product under investigation is approved, licensed, or cleared by FDA for any use, or whether the investigation is aimed at studying a “new use” (a use not covered in the labelling).Thus, if the study completes before the product or its new use are cleared by the FDA, a delay can be granted for reporting of study results.Additionally, an extension in deadline for reporting study results can be requested if “good cause” is shown for the same and an estimated date is supplied.[1]Further, there ARE penalties for not submitting results:Are There Penalties If I Fail to Register or Submit Results?FDAAA 801 establishes penalties for Responsible Parties who fail to comply with registration or results submission requirements. Penalties include civil monetary penalties and, for federally funded studies, the withholding of grant funds.See the statutory provisions amending Civil Money Penalties (PDF) and Clinical Trials Supported by Grants From Federal Agencies (PDF) for more information.Source: FDAAA 801 RequirementsHow do we track down “What is going on with this and similar trials”?There are several ways to backtrack and investigate what might have happened with any study.Digging into the specific example of “Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers”, as of March 9th, 2017, the study status shows: “This study has been completed”. The results page says “No Study Results Posted on ClinicalTrials.gov for this Study”.Firstly, as per what is available as of now, REOLYSIN® has not been cleared by FDA. In April 2015, the US FDA granted Orphan Drug Designation to Reolysin for malignant glioma. [2]Thus it is possible that this falls under the category of studies mentioned above, which may be eligible for delayed result submission.A couple of additional observations -In July 2010, Primary and Secondary endpoints were establishedThe collection of Primary endpoint data was completed in April 2012Study was marked completed May 2014Secondary endpoints were updated after study closureLooking at the sponsor website and press releases gives more information (emphasis, mine).In December 2012, Oncolytics announced positive top-line data examining initial percentage tumour changes between the pre-treatment and first post-treatment scans (typically performed at six weeks post-first treatment) of all patients enrolled in the study. Of the 105 total patients with evaluable metastatic tumours, 86% (n=50) of those in the test arm of the study exhibited tumour stabilization (defined as zero percent growth only) or shrinkage, compared with 67% of patients (n=55) in the control arm. This was statistically significant, with a p-value of 0.025. The analysis also showed that REOLYSIN® in combination with carboplatin and paclitaxel was statistically significantly better than carboplatin and paclitaxel alone at stabilizing or shrinking metastatic tumours, yielding a p-value of 0.03.In April 2014, the Company announced detailed results from the study. One hundred and eighteen patients had loco-regional disease, with or without distal metastases. Under the study conditions, test arm patients with loco-regional disease demonstrated a progression-free survival (PFS) benefit over control arm patients through five cycles of therapy. An intent-to-treat analysis of this study population showed a statistically significant improvement in PFS for the test arm versus the control arm (p=0.0072, hazard ratio=0.5360) using Type II censoring from the median PFS in each arm (48 days in the control arm and 95 days in the test arm). An intent-to-treat analysis of the patients with loco-regional disease to the median PFS in each arm also demonstrated a statistically significant improvement in overall survival (OS) for the test arm versus the control arm (p=0.0146, hazard ratio=0.5099), censoring any patients who received post-discontinuation therapy at the date on which they commenced the first of these therapies. The 118 patients with loco-regional disease, with or without distal metastases, were evaluated for percentage magnitude of tumour shrinkage at the first post-treatment scan (performed at approximately six weeks). The test arm showed a statistical trend towards increased tumour shrinkage over the control arm (p=0.076).In the April 2014 analysis, there were an additional 47 patients with distal metastases alone, eight of whom remained alive at the time of the analysis. Test arm patients with distal metastases alone showed a PFS benefit over control arm patients through five cycles of therapy; however, there were too few patients to power a statistical analysis of the PFS and OS of this patient group. The 47 patients with distal metastases alone were evaluated for percentage magnitude of tumour shrinkage at the first post-treatment scan (performed at approximately six weeks). The test arm demonstrated statistically significant increased tumour shrinkage over the control arm (p=0.021).Source: Oncolytics website[3]The results shared above are posted on the website, but neither the early results, nor the final results at the closure of the study were published. Also, more emphasis is placed on discussing “Best % Tumor Specific Response in loco-regional disease and/or metastatic disease for the treatment regimens in the study population” - a particular secondary endpoint which was submitted on ClinicalTrials.gov only in November 2014. The primary endpoint of overall survival is discussed only in patients with loco regional disease, and patients with distal metastases alone were too few to power a statistical analysis of PFS and OS.It is clear that the study was amended based on initial findings.A Reuters based news article reported on a conference call with Oncolytics President and CEO which demystifies the course of events:[…] a closer look found that patients for whom only metastatic disease was being measured were responding differently to treatment than patients who had local regional disease, with a statistically significantly greater median evolving PFS in the metastatic disease group.Because of the difference in response, Oncolytics concluded that those two patient groups ought to be considered differently, and consulted with the FDA before deciding to expand enrollment in the first stage of the trial to include 160 patients, segregating between patients with local recurrent disease, with or without metastases.That meant that the expanded first stage of the study became a separate supportive study to a planned registration study that took the place of the original second stage, resulting in a need for more time to analyze PFS from the expanded first stage.And so the further endpoints became event-driven, rather than time-driven, Thompson said in the conference call. Asked when more complete data – on PFS, overall survival (OS) and objective response rate – will be available, he could only estimate.Source: Bioworld[4]In conclusion, clinical studies face a great deal of scrutiny and regulation. Reporting of results and adverse events is now mandated in many countries. This reporting is mostly taken quite seriously by companies, and is usually a better source of getting information compared to journal articles.For anyone trying to follow the sequence of events for a given product and its related trials, several sources of information exist. These include, but are not limited to - ClinicalTrials.gov, US FDA announcements, sponsor websites and press releases, news articles from industry specific publications.Footnotes[1] FDAAA 801 Requirements[2] Reolysin - Wikipedia[3] REO 018 – Oncolytics Biotech Inc.[4] Wall Street 'Reolysin' Value; Oncolytics Soars on Phase III

Startups 101: How to Create a Business PlanThe first thing you need to do is create an executive summary and a mission statement.After that, you need to study your market, compare yourself to your competition, create a share structure, outline financials, and fill out the rest of the pertinent data like the other people suggest.Below is an example of the last executive summary and mission statement that I created for a company I was planning to launch earlier this year.Since I own the company, wrote this from scratch, and decided that I will not be launching this product, I decided to share. (Yes, it is heavily focused on marketing, but that's my primary expertise, if I'm even somewhat good at it... Who in the world knows...)I worked with a Product CEO and operated as the COO at this company and recruited a highly talented team, however the Product CEO decided to part ways so we scrapped the business.Also, you may not want to make a public benefit company unless you already have investors you can turn to for sure who don't care what kind of business you own. If you are seeking to raise money from venture capital, then it is highly unlikely that they will invest into your model.1.0 EXECUTIVE SUMMARYCompany Name | Tagline | An American Public Benefit Company Founded in February of 2013, (“SE”) features contemporary women’s fashions specializing in comfort, fit and sexiness, established by a diverse group of individuals, led by the C.E.O. Ms. Lee.SE holds idealistic aspirations of giving back to the underprivileged, creates American Jobs and gives back to the community, while keeping the clientele engaged through social interactionsSE provides:• A Philanthropic Vision.• Patriotism.• Quality Clothing.• Best Styles for women of the 21st Century.• Quality Content.• An Interactive Community.SE’s innovative design and marketing team constructs visionary product campaigns and strategies, designed to push SE to the forefront of the industry.Derived from the fictional character, Sophia Serrano, from the film Open Your Eyes, SE’s inspiration is characterized by Sophia’s radiant qualities of being: positive, down-to earth, original, mysterious, sexy, and guileless in a perfect world.Sophia is the “ideal” woman because not only is she divine in nature, she is able to cope through the greatest obstacles that obstruct her from her path. Simultaneously, Sophia is so unique, she makes a man follow her into the afterlife of his dreams. Not only did she (tagline) in the real world, she left him in need of her in the afterlife.SE wants other fashion brands and the world to know that everyone in this world matters, no matter your race, ethnicity, financial background or country of origin.SE empowers people to make a difference by:• Helping the Underprivileged Children of America.• Creating American Jobs.• Providing a more Eco-Friendly environment.All of SE’s products are made in the United States, providing more opportunities to influence economic growth.SE ensures no usable fabric goes to waste by collecting all the scraps of fabrics and donating the items to (charity), with the sole intent to create exclusive items, blankets, or articles of clothing for the less fortunate. In addition, SE donates 10% of all sales to (charity) , to help feed, clothe, and provide shelter for the less fortunate.SE plans to take a creative approach to branding and marketing the company.Not only will SE use traditional methods of marketing, such as mailing clothes to celebrities, look books to bloggers and editors, buying editorial spots, sponsoring events, and advertising online, SE will take grass root efforts to the next level in attracting hits to the website, along with social media to keep the clientele engaged.Sending celebrities, fashion editors and bloggers free gifts never guarantees the promotion of an item, so SE has decided to implement a revenue sharing program with its clothing. Each individual influencer will have a personalized URL to direct their clients to SE’s website. Each purchase made within thirty days by the referral of an “influencer” will generate an earnings check of $25 to the referrer. Checks will be cut once the accumulated balance reaches $300, or can be exchanged to store credit.SE will seek out make up artists, photographers, stylists, and other professionals within the fashion industry to provide an opportunity to earn an extra source of income through its revenue sharing program. SE will also provide clothing to stylists, to have featured in editorial along with video content.SE’s grassroots efforts will take place in the form of carefully selected event sponsorships. Through event sponsorships, models will be showcased wearing the SE product through a trade booth. SE will take pictures of celebrities who try on the products and feature blog posts through social media efforts of the celebrities, while distributing the highly sought out images to fashion bloggers. SE will then pass out $10 SE Clothing Branded Gift Cards to people who fit the role of the target consumer of the brand at the event. Initially, 50,000 gift cards will be made for distribution within the first year, of which we expect at least 25,000 to visit the website URL.SE will implement a referral based program, where if a friend is referred to purchase an item through the SE website through their email or social media link within 30 days, the customer will have the choice to have one of the following occur:• $25 will be credited to the referrer’s account for Future Purchases.• $25 will be donated to the referrer’s Charity of Choice.The referee will also receive $10 credited off their first purchase. Studies indicate that 1 out of every 3 customers will refer their friends to a site that they trust and enjoy.SE will partner with publishers and affiliates such as Google Affiliate, Commission Junction, Avantlink, Affiliate Window, Webgains, Pepperjam, Integrate, Etc. to allow professionals to earn a profit by referring their clientele to purchase items from SE.In order to create better organic SEO (Search Engine Optimization) results to guide more online traffic to the website, SE will carry lines of both popular name brand and up-and-coming American Made products by other designers, such as Nasty Gal, Diesel, Ralph Lauren, Armani, Etc. In order to acquire the product necessary, SE will create a strategic partnership with its manufacturer to sell their excess inventory.Once new customers visit the SE site, they will be given an opportunity to register on the site to claim their $10 credit. Through registration, information such as the customer’s name, email address, phone number, address, and social media profiles will be gathered.Once the customer registers, they will be able to access the site. A welcome email will be sent to the customer within one day, welcoming them to the site. Within 5-7 business days, a letter stating SE’s appreciation of the customer with an outline of the brand’s philanthropic vision will be physically mailed to the customer on company letterhead and hand signed by the C.E.O., Ms. Lee. The customer will then be emailed, informing them that their gift card will expire in 30 days, 3 weeks, 15 days, 7 days, 3 days, 2 days, and a final offer email. This cycle will repeat for another 30 days for a total of 60 days, which will trigger a sense of urgency within purchasing an item within the allotted timeframe.SE will engage with customers by providing the first few sentences of educational content through email, while providing links to the blogging section of the website to read the full article, along with social media efforts on Pinterest, Facebook, Twitter, DeviantART, Tumblr, Google+, Polyvore, Wanelo, Quora, Lyst, Etc. to build trust with the clientele, and keep them engaged with the brand. SE will track user activity through analytic services provided by Kissmetrics to measure which campaigns work best, to better understand our audience.SE will influence increases in transaction sizes by donating one item to charity for every $300 spent in a single transaction. Not only would revenues increase, the philanthropic vision would accelerate to creating a bigger influence to society, which in turn will create a better image for the brand.SE will have a section on the site where users can upload images of their new purchases, how they pair their outfits, provide feedback to others, and like other consumer’s styles, creating an engaged society of buyers who become advocates and prosumers of the brand.SE will begin sales on the retail website, then slowly trickle into many online boutique stores, physical boutique stores, then into major department stores. Since bulk purchases from vendors decrease manufacturing costs, the business model is extremely scalable. As SE becomes a more established brand, price increases will be implemented in 10% increments per season, increasing profit margins while manufacturing costs decrease.SE will create separate databases for consumers who have at least purchased one item and another database for loyal consumers. In regard to the database of consumers who have purchased, collateral material providing a promo code for a promotional discount will physically be mailed to the clients two weeks prior to an anniversary or holiday sale, to provide exclusive access to the promotion. SE will randomly select users from the loyal consumer database to provide a free gift with purchase, expedited or free shipping, and various other promotional tools to reward brand loyalty.Once SE establishes a loyal client base, verticals will be integrated one product at a time in minimal quantities, initially to test the market to see how well the product does. Verticals will range from products such as cosmetics, shoes, handbags, hats, stockings, scarves, jewelry, and other womenswear based products.Led by C.E.O. Ms. Lee, SE has hand selected a managerial team of 8 creative unique individuals to grasp a portion of the $500+ billion dollar market by creating quality content, negotiating with vendors, managing finances, and laying out the long term growth of the company, all while creating beautiful product.10 years from now, in the year 2023, SE plans to be acquired by LVMH, PPR, Richemont, Valentino Fashion Group, The Aeffe Group, Puig, Diesel, Phillips-Van Huesen, Hermes, Liz Claiborne, Inditex, The Arcadia Group, or Aurora Fashion for a strike price of $300 million. SE is currently seeking seed financing in the amount of $275,000 to be used to cover manufacturing, marketing, legal and operational expenses to establish the brand.MISSION STATEMENTUnited together, SE’s commitments to society are as follows:#1. To Mother Earth:We vow to make sure that no usable fabric is wasted. All usable scrap material will be recycled into specialty items, blankets or created into articles of clothing for the less fortunate.#2. To Our Nation:We vow to Shop American. We vow to only manufacture our product in America. We are creating American jobs and doing our part in rebuilding the American economy.#3. To Our World:We vow to take a stance against child labor. We take a stance against the Chinese sweatshops with hazardous work conditions.#4. To The Less Fortunate:We vow to provide food, clothing, and shelter for children who are unable to take care of themselves, especially the ones right here at home.#5. To Our Customers:We vow to make sure you feel beautiful and (tagline). We vow to create the sexiest, most reliable products made from the best material we can find. We will provide the best fit possible. We will listen to your opinions and make decisions based off of your feedback. Your voice will be heard.#6. To Our Design PartnersWe vow to provide our client base accessibility to your designs to increase your exposure in the market place. Whether you are a small designer who is just beginning or an established brand, there is a place here for you to showcase your items, as long as the product is manufactured here in America.#7. To Our Employees:We vow to bring the jobs back home and provide fair wages. We vow to provide a fun and friendly stress-free work environment.#8. To Our Shareholders:We vow to provide you a seat on our board. We vow to listen to your expertise. We vow to provide returns in a timely manner. We vow to fulfill your philanthropic vision.Oh, it might be in your best interest to include a mind map as well.The first five pages should include the following information:BUSINESS DEVELOPMENT PLANMARCH 2013****** CONFIDENTIALITY & DISCLOSURE NOTICE ******IMPORTANT: This document is for information purposes only and sent at your request and is covered by the Electronic Communications Privacy Act 18 U.S.C. 2510‐2521. This is neither a solicitation of investment nor an offer to sell and/or buy securities. This communication may contain non‐public, private, confidential or legally privileged information and documents intended for the sole use of the designated recipient(s). The unlawful interception, use or disclosure of such information is strictly prohibited under the applicable laws of the U.S.A. and the State of Nevada. Any review, retransmission, dissemination or other use of, or taking of any action in reliance upon this information by persons/entities other than the intended recipient is prohibited. If you received this document and / or a transmission of this document in error, delete any electronic copies of this document and / or return this document to (Name, Address)CONFIDENTIALITY & DISCLOSURE NOTICEIMPORTANT: This document is for information purposes only and sent at your request and is covered by the Electronic Communications Privacy Act 18 U.S.C. 2510-2521. This is neither a solicitation of investment nor an offer to sell and/or buy securities. This communication may contain non-public, private, confidential or legally privileged information and documents intended for the sole use of the designated recipient(s). The unlawful interception, use or disclosure of such information is strictly prohibited under the applicable laws of the U.S.A. and the State of California. Any review, retransmission, dissemination or other use of, or taking of any action in reliance upon this information by persons/entities other than the intended recipient is prohibited. If you received this document and / or a transmission of this document in error, delete any electronic copies of this document and / or return this document to (Name, Address)CONFIDENTIALITY AGREEMENTThe undersigned reader acknowledges that the information provided within this Business Development Plan (“BDP”) is confidential; therefore, reader agrees not to disclose it without the express written permission of SE.It is acknowledged by reader that information to be furnished in this BDP is in all respects confidential in nature, other than information which is in the public domain through other means and that any disclosure or use of same by reader, may cause serious harm or damage to SE and other sources identified herein. The information, estimates and projections contained herein have been prepared by SE in good faith and on a basis believed to be reasonable; such estimates and projections involve significant elements of subjective judgment and analysis. No representation or warranty, expressed or implied, can be made as to the accuracy or completeness of such information, and nothing contained in this BDP is, or shall be relied upon as, a promise or representation as to the past or the future. This BDP is submitted in connection with the evaluation of a potential transaction and may not be reproduced or used, in whole or in part, for any other purpose.Upon request, this document is to be immediately returned SE,.___________________Signature___________________Name (typed or printed)___________________DateThis is a Business Development Plan. It does not imply an offering of securitiesFORWARD LOOKING STATEMENTThis document may contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, but not limited to, statements as to future operating results and plans that involve risks and uncertainties. We use words such as “expects”, “anticipates”, “believes”, “estimates”, the negative of these terms and similar expressions to identify forward looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by those projected in the forward-looking statements for any reason. References herein to “the Company,” “we,” “our,” “us” and similar words or phrases are references to SE, and/or its subsidiaries, unless the context otherwise requires.CONTACT INFORMATIONInquiries may be directed to the appropriate party below:Leonard KimCOOSEAddress:Phone:Fax:Email:The Table of contents should include the following information that no one, aside from analysts read:TABLE OF CONTENTS1.0 EXECUTIVE SUMMARY1.1 OBJECTIVES1.2 MISSION1.3 KEYS TO SUCCESS2.0 COMPANY SUMMARY2.1 CAPITALIZATION SUMMARY2.2 COMPANY LOCATIONS AND FACILITIES.3.0 PRODUCTS AND SERVICES3.1 THE SE TECHNOLOGY3.2 COMPETITIVE COMPARISON3.3 MARKETING MATERIAL3.4 TECHNOLOGY FULFILLMENT3.5 FUTURE PRODUCTS AND SERVICES4.0 MARKET ANALYSIS SUMMARY4.1 MARKET SEGMENTATION4.2 TARGET MARKET SEGMENT STRATEGY4.2.1 MARKET NEEDS4.2.2 MARKET TRENDS4.2.3 MARKET GROWTH4.3 SERVICE BUSINESS ANALYSIS4.3.1 BUSINESS PARTICIPANTS4.3.2 DISTRIBUTING A PRODUCT4.3.3 MAIN COMPETITORS5.0 WEB PLAN SUMMARY5.1 WEBSITE MARKETING STRATEGY5.2 DEVELOPMENT REQUIREMENTS6.0 STRATEGY AND IMPLEMENTATION SUMMARY6.1 SWOT ANALYSIS6.1.1 STRENGTHS6.1.2 WEAKNESSES6.1.3 OPPORTUNITIES6.1.4 THREATS6.2 STRATEGY PYRAMID6.3 VALUE PROPOSITION6.4 COMPETITIVE EDGE6.5 MARKETING STRATEGY SUMMARY6.5.1 POSITIONING STATEMENT6.5.2 PRICING STRATEGY6.6 SALES STRATEGY6.6.1 SALES FORECAST6.7 MILESTONES7.0 MANAGEMENT SUMMARY7.1 ORGANIZATIONAL STRUCTURE7.2 MANAGEMENT TEAM7.3 MANAGEMENT TEAM GAPS7.4 PERSONNEL PLAN8.0 FINANCIAL PLAN8.1 START-UP FUNDING8.2 KEY FINANCIAL INDICATORS8.3 BREAK-EVEN ANALYSIS8.4 PROJECTED PROFIT AND LOSS8.5 PROJECTED CASH FLOW8.6 PROJECTED BALANCE SHEET8.7 BUSINESS RATIOS8.8 THE INVESTMENT OFFERING8.9 VALUATION8.10 USE OF FUNDS9.0 APPENDICESTABLE: SALES FORECASTTABLE: PROFIT AND LOSSTABLE: PROFIT AND LOSSTABLE: CASH FLOWTABLE: CASH FLOWTABLE: BALANCE SHEETIf you're using a business plan to try to attain a loan for a small business... I took a different business plan for a nightlife company, brought a cofounder with a 680 credit score, and went to Long Beach SBDC and they helped me get approved for a loan from a credit union for $30,000 two years ago. The whole process took less than a week, since we already had our business plan finished prior to showing up. We ended up not taking the loan because our programmer ran off with the money we had paid him prior without delivering our technology.There are Small Business Development Centers, sponsored by the Small Business Association, all across the United States that will help you make a business plan for free, read it, and even shop it out for business loans.If you're using a business plan to attain financing from an Angel Investor or VC, then all that matters is your executive summary and your slideshow. I mean, you still need the other data filled in, but these are the only two areas of which they put their main focus on. However, a lot of investors use two financial analysts to carefully go over every detail within a business plan prior to investing their own cash. So, the fine details are pretty important regardless of what anyone else says.Also, if you need to know how to split equity with your startup, read more here: How much equity do you give early employees when the company is bootstrapped?Read more at my blog: Startups 101: How to Create a Business Plan